ARCHIVES

DeVita Resigns As No. 2 At Sloan-Kettering To “Pursue Clinical Research,” Hospital Says

This article is from The Cancer Letter archive.

Vol. 17 No. 22 | May 31, 1991

Download PDF Visit The Full Archive

Related Articles

Other NCI funding opportunities listed.

July 9, 2004

FDA Approves Tamoxifen For DCIS Folowing Breast Surgery And Radiation.

July 28, 2000

In Brief: Hammond Resigned As ACS Officer; Wykoff Slated To Direct FDA Special Populations Office

November 20, 1992

In Brief: Former Oklahoma Re. Synar, Opponent of Tobacco, dead at 45 Of Brain Cancer

January 12, 1996

NCI Implementing Changes In Organ Site Program, Directing Grant applications To NIH Study Sections

October 15, 1982

Viral Oncology Not Losing $5 Mil. This Year – But Watch Out for ‘79

January 6, 1978